KALBE GENEXINE BIOLOGICS
Kalbe Genexine Biologics is developing innovative biologic therapy for high unmet medical needs in largely underserved areas.
KALBE GENEXINE BIOLOGICS
Industry:
Biotechnology Life Science
Founded:
2016-01-01
Address:
Jakarta, Jakarta Raya, Indonesia
Country:
Indonesia
Website Url:
http://www.kg-biologics.com
Total Employee:
1001+
Status:
Active
Contact:
(6221) 42873888
Total Funding:
55 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro GStatic Google Static Content Wix
Similar Organizations
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Principia Biopharma
Principia Biopharma is dedicated to bringing oral therapies to patients with significant unmet medical needs in immunology & oncology.
Current Employees Featured
Investors List
General Atlantic
General Atlantic investment in Private Equity Round - Kalbe Genexine Biologics
Official Site Inspections
http://www.kg-biologics.com Semrush global rank: 5.57 M Semrush visits lastest month: 1.52 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Kalbe Genexine Biologics"
About us - KGbio
KGbio is a clinical-stage biotechnology company established in 2016, focused on bringing biologics medical innovation to markets outside the US/Canada, Western Europe and China. The business model revolves around in-licensing novel โฆSee details»
Kalbe Genexine Biologics - Crunchbase Company Profile & Funding
When was the last funding round for Kalbe Genexine Biologics? Kalbe Genexine Biologics closed its last funding round on Jan 26, 2021 from a Private Equity round. Who are Kalbe Genexine โฆSee details»
321b9370-a2ba-42c1-9ff1-f0bdc3d1c682 - KGbio
Sep 23, 2021 General Atlantic, a leading worldwide growth equity firm that invests in and supports early-stage companies strategically, will invest US$55 million in primary capital in Kalbe Genexine Biologics (โKGbioโ or โthe โฆSee details»
General Atlantic to Invest US$55 Million in Kalbe Genexine Biologics
Jan 26, 2021 About Kalbe Genexine Biologics (KGBio) KGBio aims to provide high-quality, affordable, and innovative biologics, biosimilars, and immuno-oncology products to the โฆSee details»
KGbio - Products, Competitors, Financials, Employees, โฆ
BRIEFโHenlius' serplulimab approved in Indonesia. Dec 29, 2023. 28-12-2023 Shanghai Henlius Biotech has announced that PT Kalbio Global Medika, the subsidiary of Henlius' partner PT โฆSee details»
Henlius and KG Bio Enter into Exclusive License Agreement for โฆ
Sep 30, 2019 Henlius (2696.HK) and PT Kalbe Genexine Biologics (hereinafter referred to "KG Bio"), a holding subsidiary to PT Kalbe Farma, Tbk (hereinafter referred to "Kalbe Farma"), an โฆSee details»
Genexine
<2023-10-23> Genexine (KQ 095700, CEO Sungjune Hong), a publicly-listed clinical-staged Korean biopharmaceutical company committed to the discovery and development of novel โฆSee details»
Home - Celonic โ Beyond Biomanufacturing
Celonic โ A Quality Swiss-based Biologics CDMO The Celonic Group is a โPure Playโ Biologics Contract Development Manufacturing Organization (CDMO). Celonicโs mission is to help its clients, primarily small to large Biotech and โฆSee details»
Solved Select a specific type of biotechnology organization - Chegg
Select a specific type of biotechnology organization such as fermentation, biologics, or gene therapy and evaluate the risk of technology from a business perspective. Your solutionโs ready โฆSee details»
Biocon Biologics - Multiple Openings for B.Sc, B.Pharm, M.Pharm, โฆ
20 hours ago Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and โฆSee details»
Marine Biologics - Crunchbase Company Profile & Funding
Marine Biologics manufactures macroalgae-based ingredient systems for the food and beverage industry. The company uses curated compositional data, formulation AI, and green processing โฆSee details»
Products and Services - KGbio
ASSETS INDICATIONS REGIMEN PHASE I PHASE II PHASE III REGISTRATION COMMERCIAL NOVEL BIOLOGICS NIMOTUZUMAB EGFR monoclonal antibody Glioma & โฆSee details»
Samsung Biologics bags CMO deals worth W468b - ํค๋ด๋๊ฒฝ์
May 22, 2020 Samsung Biologics has bagged two contract manufacturing deals worth 468 billion won ($378 million) combined, according to its regulatory filing on May 22. The total value of โฆSee details»
Inauguration of the new Richter BioLogics cGMP facility for the ...
Sep 16, 2024 About Richter BioLogics GmbH & Co KG Richter BioLogics is a leading Germany-based contract development and cGMP manufacturing organization with its headquarters โฆSee details»
Home - Kolosis BIO
MTF Biologics is a global nonprofit and physician-led organization, headquartered in Edison, New Jersey. MTF Biologics has spent more than 30 years honoring donated gifts by developing โฆSee details»
NewsEvents - KGbio
Oct 19, 2022 General Atlantic US Invests US$55 Million in Kalbe Genexine Biologics. General Atlantic, a leading worldwide growth equity firm that invests in and supports early-stage โฆSee details»
Samsung Biologics hosts ESG event with suppliers to strengthen ...
1 day ago Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today hosted its second Supplier ESG Day to share โฆSee details»
Samsung Biologics hosts ESG event with suppliers to strengthen ...
1 day ago INCHEON, South Korea, Dec. 3, 2024 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today โฆSee details»
Samsung Biologics hosts ESG event with suppliers to strengthen ...
1 day ago INCHEON, South Korea, Dec. 3, 2024 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), tod โฆSee details»